BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16775991)

  • 1. [Cervical cancer screening: current status and perspectives].
    Petignat P; Bouchardy C; Sauthier P
    Rev Med Suisse; 2006 May; 2(66):1308-9, 1311-2. PubMed ID: 16775991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Integrating HPV testing for primary screening?].
    Riethmuller D; Ramanah R; Pretet JL; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV testing and cervical cancer screening: recommendations and practice patterns.
    Madom LM; Boardman LA
    Med Health R I; 2005 Oct; 88(10):362-3. PubMed ID: 16353376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
    Sasagawa T
    Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening.
    Holcomb K; Runowicz CD
    Surg Oncol Clin N Am; 2005 Oct; 14(4):777-97. PubMed ID: 16226691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis].
    Martinelli D; Chironna M; Tafuri S; Neve A; Caputi G; Prato R; Germinario C; Quarto M
    Ann Ig; 2007; 19(6):499-508. PubMed ID: 18376570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
    Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
    Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer incidence and mortality in the best and worst of worlds.
    Rydström C; Törnberg S
    Scand J Public Health; 2006; 34(3):295-303. PubMed ID: 16754588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.
    Franco EL; Ferenczy A
    Future Oncol; 2007 Jun; 3(3):319-27. PubMed ID: 17547527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.